Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Ignores Tobacco Harm Reduction As Therapeutic Option – Experts

Apr 18 2011

• By Malcolm Spicer

Related Content

Advisory Committee On NRT Indications Appears Likely Following Workshop

Nov 01 2010

FDA Will Mull OTC Smoking Cessation Long-Term Use As Support Builds

Sep 06 2010

FDA's Tobacco Center To Mull First Modified-Risk Claim Application

Mar 01 2010

Additional Topics

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window